Nathan L. Mata

Chief Scientific Officer, Belite Bio, Inc

Bought, 12 months

$0.0M

Sold, 12 months

$2.7M

Companies

Latest trade

May 7, 2026

Companies

Belite Bio, IncChief Scientific Officer −$2.7M

Trades

BLTE Sold 666 shares at $153.21 · planned $0.1M May 7

BLTE Sold 1,000 shares at $153.84 · planned $0.2M May 6

BLTE Sold 1,000 shares at $155.50 · planned $0.2M May 5

BLTE Sold 1,000 shares at $155.64 · planned $0.2M May 4

BLTE Sold 1,000 shares at $155.78 · planned $0.2M May 1

BLTE Sold 1,000 shares at $156.97 · planned $0.2M Apr 30

BLTE Sold 1,000 shares at $155.82 · planned $0.2M Apr 29

BLTE Sold 1,000 shares at $159.16 · planned $0.2M Apr 28

BLTE Sold 1,000 shares at $162.64 · planned $0.2M Apr 27

BLTE Sold 1,000 shares at $159.56 · planned $0.2M Apr 24

BLTE Sold 1,000 shares at $166.28 · planned $0.2M Apr 23

BLTE Sold 1,000 shares at $170.39 · planned $0.2M Apr 22

BLTE Sold 1,000 shares at $166.00 · planned $0.2M Apr 21

BLTE Sold 1,000 shares at $163.60 · planned $0.2M Apr 20

BLTE Sold 1,000 shares at $161.63 · planned $0.2M Apr 17

BLTE Sold 1,000 shares at $160.38 · planned $0.2M Apr 16

BLTE Sold 1,000 shares at $168.30 · planned $0.2M Apr 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.